Influenza Vaccine Market Size, Share & Industry Analysis, By Type (Inactivated and Live Attenuated), By Valency (Quadrivalent and Trivalent), By Age Group (Pediatric and Adults), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others), and Regional Forecast, 2024-2032

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2023

Estimated Year

2024

Forecast Period

2024-2032

Historical Period

2019-2022

Growth Rate

CAGR of 9.6% from 2024-2032

Unit

Value (USD Billion)

Segmentation

By Type

• Inactivated


• Live Attenuated

By Valency

• Quadrivalent


• Trivalent

By Age Group

• Pediatric


• Adults

By Distribution Channel

• Hospital & Retail Pharmacies


• Government Suppliers


• Others

By Region

• North America (By Type, By Valency, By Age Group, By Distribution Channel, and By Country)




• U.S. (By Valency)


• Canada (By Valency)




• Europe (By Type, By Valency, By Age Group, By Distribution Channel, and By Country/Sub-region)




• U.K. (By Valency)


• Germany (By Valency)


• France (By Valency)


• Italy (By Valency)


• Spain (By Valency)


• Scandinavia (By Valency)


• Rest of Europe (By Valency)




• Asia Pacific (By Type, By Valency, By Age Group, By Distribution Channel, and By Country/Sub-region)




• Japan (By Valency)


• Korea (By Valency)


• China (By Valency)


• India (By Valency)


• Australia (By Valency)


• Rest of Asia Pacific (By Valency)




• Latin America (By Type, By Valency, By Age Group, By Distribution Channel, and By Country/Sub-region)




• Brazil (By Valency)


• Mexico (By Valency)


• Rest of Latin America (By Valency)




• Middle East & Africa (By Type, By Valency, By Age Group, By Distribution Channel, and By Country/Sub-region)




• GCC (By Valency)


• South Africa (By Valency)


• Rest of Middle East & Africa (By Valency)